Microneedling vs. Microneedling With Exosomes: Which Is Better?

If you’re comparing microneedling vs. microneedling with exosomes, the most important distinction is that conventional microneedling is the established procedure, while adding an exosome-containing product represents an emerging approach that is still being studied.

At Azani Medical Spa in Bethlehem, PA, patients considering microneedling can discuss whether conventional microneedling is appropriate for their goals and whether an exosome-containing treatment is worth considering based on the current evidence, product characteristics, risks and regulatory status.

The short answer is this: microneedling has a substantially more established evidence base, while microneedling with exosomes may offer additional benefits but has not yet been proven superior to conventional microneedling.

At a Glance: Microneedling vs. Microneedling With Exosomes

Bottom line: If your priority is the treatment with the stronger established evidence base, conventional microneedling currently has the advantage. If you’re considering exosomes, the decision should be based on the specific product, treatment protocol, evidence supporting that product, your skin concern and an informed discussion of uncertainty.

What Is Conventional Microneedling?

Microneedling is a minimally invasive procedure that uses fine needles to create controlled microscopic injuries in the skin.

The goal is not to damage the skin randomly. Rather, controlled needle penetration initiates a wound-healing response involving processes associated with tissue remodeling.

Depending on the device, treatment settings and indication, microneedling may be used to improve the appearance of:

• Fine lines
• Facial wrinkles
• Certain acne scars
• Uneven skin texture
• Some signs of photodamage
• Other selected cosmetic concerns

The FDA has legally authorized certain microneedling devices for specific uses, including improving the appearance of facial acne scars, facial wrinkles and abdominal scars in patients aged 22 and older.

That authorization is device- and indication-specific. It does not mean that every microneedling device or every use of microneedling has FDA authorization.

What Is Microneedling With Exosomes?

Microneedling with exosomes combines conventional microneedling with an exosome-containing preparation.

Exosomes are extracellular vesicles involved in communication between cells. They can carry biologically active molecules, and researchers are investigating their potential roles in processes such as:

• Cellular signaling
• Inflammation
• Tissue repair
• Wound healing
• Collagen and extracellular-matrix activity
• Skin aging
• Pigmentation
• Scar remodeling

This creates a biologically interesting hypothesis:

Could an exosome-containing product enhance the skin-remodeling response initiated by microneedling?

That is one of the questions researchers are investigating. But biological plausibility is not the same as clinical proof.

A treatment can have a compelling mechanism and still require much more research before we know whether it produces a meaningful additional benefit for patients.

Microneedling vs. Microneedling With Exosomes: How Do They Actually Differ?

The simplest way to understand the difference is to separate the two components.

Conventional microneedling

The procedure itself is the treatment. The needles create controlled micro-injuries that stimulate a wound-healing and remodeling response.

Microneedling with exosomes

The same type of microneedling procedure is performed, but an exosome-containing product is added to the treatment protocol. The theoretical advantage is that the exosome preparation may provide additional biological signaling during the period of tissue repair.

The critical question is therefore:

Does the added product produce better clinical outcomes than microneedling alone?

That question is much more important than whether exosomes have interesting biological properties.

Is Microneedling With Exosomes Better Than Regular Microneedling?

Not definitively.

This is one of the most important conclusions patients should understand.

There are human studies suggesting that adding an exosome-containing preparation may improve certain measures of skin appearance. However, the available studies are generally small, use different products and protocols, and do not establish a universal superiority over conventional microneedling.

A 2026 systematic review specifically examining microneedling combined with exosomes identified 256 unique references, but only eight studies ultimately met the criteria for final narrative synthesis. Study sizes ranged from only 3 to 60 participants. The authors concluded that additional research with larger samples and longer follow-up is needed.

That is promising—but it is not the same as saying that exosome microneedling has been proven superior.

What Does the Evidence Say About Conventional Microneedling?

The evidence base for conventional microneedling is considerably larger.

A 2025 systematic review of microneedling for facial rejuvenation identified 346 studies during its search and ultimately included 21 studies involving 723 patients.

The most frequently studied outcomes included:

• Wrinkles
• Skin texture
• Photoaging
• Skin laxity

Nineteen of the 21 studies used multiple treatment sessions.

A pooled analysis found that approximately 83% of patients reported satisfaction, although the authors also emphasized that standardized methods for measuring aesthetic outcomes remain limited.

The most commonly reported adverse effects were transient erythema, scaling, burning and pruritus. This does not mean microneedling is perfect or universally effective.

It means that conventional microneedling has a larger and more mature clinical literature than the combination of microneedling and exosomes.

What Does the Evidence Say About Microneedling With Exosomes?

The evidence is newer and considerably smaller.

A 2026 systematic review specifically evaluating microneedling with exosomes found studies involving:

• Skin aging
• Hyperpigmentation
• Scarring
• Enlarged pores
• Androgenetic alopecia

The review found encouraging signals but concluded that larger studies and longer follow-up are necessary to establish efficacy and long-term safety more confidently.

This is an important distinction:

What the research suggests

Exosome-assisted microneedling may improve certain skin outcomes.

What the research does not yet establish

It does not establish:

• One universally superior exosome product
• One optimal concentration
• One ideal treatment depth
• One standardized treatment schedule
• Long-term durability
• Long-term safety
• Superiority over conventional microneedling for all patients
• Equivalent results across different exosome preparations

One of the Most Important Human Studies

One frequently discussed study was a prospective, randomized, split-face study involving 28 individuals. Each participant received three treatment sessions.

One side of the face received:

Exosome-containing solution + microneedling while the opposite side received: Saline + microneedling

The investigators reported greater improvement on the exosome-treated side in measures involving:

• Overall aesthetic improvement
• Wrinkles
• Elasticity
• Hydration
• Pigmentation

No serious adverse events were reported during the study period.

This is useful evidence because the split-face design allows each participant to serve as his or her own control. However, there are still important limitations.

The study was small, follow-up was limited, and the results involved a particular exosome-containing preparation. Therefore, it does not prove that every product marketed as an “exosome” will produce the same results.

Why Product Differences Matter So Much

The word “exosomes” does not describe one standardized cosmetic or pharmaceutical product.

Preparations can differ according to:

• Biological source
• Human versus plant origin
• Manufacturing process
• Isolation method
• Purification
• Concentration
• Characterization
• Storage
• Formulation
• Stability
• Delivery method

This is one reason it is difficult to generalize from one clinical study to every product on the market.

A 2026 scoping review of topical exosomes for skin rejuvenation found substantial heterogeneity in commercially available products and noted that information about isolation, processing and shelf life was often limited.

Therefore:

A study showing benefit from one exosome preparation does not automatically establish the safety or effectiveness of another preparation.

This is particularly important when evaluating online marketing claims.

Which Treatment Is Better for Wrinkles?

For facial wrinkles, both approaches may be reasonable areas of consideration, but the evidence is stronger for conventional microneedling.

Microneedling has been studied as a non-surgical approach to facial rejuvenation, with clinical research reporting improvements in wrinkles, texture and other measures of photoaging.

Exosome-assisted microneedling has produced encouraging findings in smaller studies.

The scientifically responsible conclusion is:

Exosomes may provide an additional benefit, but it has not yet been established that adding exosomes consistently produces better wrinkle improvement than microneedling alone.

Patient factors also matter.

Wrinkles caused primarily by:

• Loss of facial volume
• Muscle activity
• Significant skin laxity
• Deep structural aging

Depending on the individual, other treatments may be more appropriate or may complement microneedling.

Which Treatment Is Better for Acne Scars?

Microneedling has a more established role in improving the appearance of certain atrophic acne scars.

The best candidates tend to have scar patterns that can respond to controlled collagen remodeling. However, not every scar responds equally.

For example:

• Rolling scars may respond to collagen-remodeling procedures.
• Some boxcar scars may improve.
• Deep ice-pick scars may require different or additional approaches.
• Strongly tethered scars may require subcision or another treatment strategy.

Exosomes are being investigated as a potential adjunct to procedures for acne scarring, but the evidence for exosome-enhanced microneedling specifically remains much less mature.

Therefore, if acne scarring is the primary concern, scar type should be assessed before deciding whether adding an exosome-containing product is worthwhile.

Which Treatment Is Better for Hyperpigmentation?

This question requires particular caution.

Microneedling may be used in selected pigmentation disorders, but the underlying diagnosis matters.

Dark spots can result from:

• Solar lentigines
• Melasma
• Post-inflammatory hyperpigmentation
• Acne-related pigmentation
• Hormonal influences
• Medication effects
• Other inflammatory or dermatologic conditions

Microneedling can sometimes be helpful, but creating additional inflammation in a person prone to post-inflammatory hyperpigmentation can also create a pigmentation problem.

Early research involving exosome-assisted microneedling has reported improvements in pigmentation, but these studies are generally small and often involve multiple simultaneous interventions. Therefore, neither conventional microneedling nor exosome microneedling should be presented as a universal treatment for “dark spots.”

The diagnosis comes first.

What About Skin Texture and Overall Rejuvenation?

This is an area where both approaches may have potential.

Conventional microneedling can improve the appearance of:

• Uneven texture
• Fine lines
• Some superficial scars
• Certain signs of photodamage

Exosome-containing treatments are being studied for potentially improving:

• Texture
• Hydration
• Elasticity
• Pigmentation
• Wrinkles
• Overall appearance

The difference is the strength of evidence.

Conventional microneedling has a more established clinical foundation.

Exosome-assisted microneedling has promising but preliminary evidence.

Is Microneedling With Exosomes More Painful?

Not necessarily.

The discomfort associated with treatment depends primarily on factors such as:

• Needle depth
• Treatment area
• Device
• Treatment intensity
• Individual pain sensitivity
• Use of topical anesthetic

Adding an exosome-containing topical preparation does not necessarily make the needle procedure itself more painful. However, patients should ask exactly what product is being used and how it is being applied.

Does Exosome Microneedling Have More Downtime?

Not necessarily, but this depends on the protocol.

The amount of downtime associated with microneedling is influenced by:

• Needle depth
• Number of passes
• Treatment intensity
• Skin sensitivity
• Area treated
• Individual healing response
• Additional products or procedures used

After microneedling, temporary effects may include:

• Redness
• Sensitivity
• Tightness
• Dryness
• Scaling or peeling
• Mild swelling
• Bruising
• Pinpoint bleeding

Adding an exosome-containing product does not automatically mean more downtime, but the safety and tolerability of the specific preparation must also be considered.

What Are the Risks of Conventional Microneedling?

Microneedling is a medical procedure when performed with a medical device that penetrates living skin layers.

Potential risks include:

• Redness
• Swelling
• Burning or stinging
• Itching
• Tightness
• Peeling
• Bruising
• Bleeding
• Infection
• Pigment changes
• Herpes reactivation
• Skin injury or scarring in uncommon circumstances

The risk profile depends on the device, treatment settings, patient characteristics and technique.

Proper infection-control practices are particularly important.

What Additional Risks Come From Adding Exosomes?

This is where the comparison becomes more complicated. The microneedling component has a known procedural risk profile.

The exosome-containing product introduces another variable.

Because there is no FDA-approved exosome product establishing a standardized safety profile for aesthetic use, safety may vary according to the preparation itself.

Questions include:

• What is the source?
• How was it manufactured?
• How was it purified?
• How is it stored?
• What contaminants are possible?
• What exactly is in the formulation?
• Has the exact product been studied in humans?
• Was the study performed using the same route of administration?

These questions matter because “exosome” is not a guarantee of a standardized composition.

Are Exosomes FDA Approved?

No.

The FDA states that there are currently no FDA-approved exosome products. That is an important distinction from the regulatory status of certain microneedling devices.

A clinic should not describe a commercially available exosome preparation as an “FDA-approved exosome.” FDA also regulates exosome products intended to treat diseases or conditions in humans as applicable under federal drug and biologic regulations.

Therefore, patients should be cautious when marketing language suggests that an exosome product is FDA-approved merely because the manufacturer or clinic makes a regulatory claim.

Is Microneedling FDA Approved?

The wording matters.

It is too broad to say: “Microneedling is FDA approved.”

The more accurate statement is: Certain microneedling devices have FDA marketing authorization for specific indications.

FDA has legally authorized specific microneedling devices for improving the appearance of facial acne scars, facial wrinkles and abdominal scars in patients aged 22 and older. That authorization applies to particular devices and indications.

It does not mean that every microneedling procedure has been evaluated or authorized.

Has FDA Cleared Microneedling With Exosomes?

No.

FDA states that microneedling devices have not been cleared for use with another product. This distinction is especially important for exosome treatments.

FDA has not reviewed the safety or effectiveness of combining a microneedling device with another product simply because the microneedling device itself has FDA authorization for a particular indication.

Therefore, the phrase:

“FDA-approved exosome microneedling” is not an accurate description of the current regulatory landscape.

So Why Do People Add Exosomes to Microneedling?

The rationale is biologically interesting. Microneedling creates controlled tissue injury and initiates a wound-healing response. Exosomes are being studied for their ability to influence cellular communication and signaling.

Researchers therefore hypothesize that combining the two could potentially create a more favorable environment for:

• Tissue remodeling
• Collagen-related activity
• Skin repair
• Hydration
• Elasticity
• Pigmentation improvement
• Overall rejuvenation

The hypothesis is reasonable enough to justify research. But the critical question remains: Does that biological rationale translate into a clinically meaningful advantage for patients? We do not yet have enough high-quality evidence to answer that universally.

What Does “Promising” Actually Mean?

In aesthetic medicine, the word “promising” can easily be misunderstood.

When researchers describe exosome therapy as promising, they generally mean that early findings justify further investigation.

It does not necessarily mean:

• Proven effective
• FDA approved
• Better than existing treatment
• Appropriate for everyone
• Long-term safe
• Guaranteed to work

For exosome microneedling, “promising” is an appropriate description of the current research landscape.

“Proven superior” is not.

Microneedling vs. Microneedling With Exosomes: The Evidence Hierarchy

A useful way to think about the two treatments is:

Conventional microneedling

Evidence level: more established

There are multiple clinical studies and systematic reviews evaluating microneedling for facial rejuvenation and other indications.

Microneedling with exosomes

Evidence level: emerging

Human studies exist, including controlled studies, but they are generally smaller and use heterogeneous products and protocols.

Long-term comparative evidence

Still lacking

We do not yet have enough large, well-controlled, long-term studies directly comparing standardized exosome microneedling with standardized conventional microneedling across different patient populations.

That missing evidence is precisely why it is too early to declare one treatment universally better.

Which Treatment Should You Choose?

There is no single answer for every patient.

Conventional microneedling may make more sense when:

• You want a treatment with a more established evidence base.
• Your primary concern is skin texture.
• You are treating certain facial wrinkles.
• You have selected atrophic acne scars.
• You prefer a simpler treatment approach.
• You do not want the additional uncertainty associated with an emerging product category.

Microneedling with exosomes may be worth discussing when:

• You are interested in emerging regenerative-aesthetic approaches.
• Your provider can clearly identify the exact product being used.
• You understand that exosome products are not FDA-approved.
• You understand that superiority over conventional microneedling has not been established.
• You have discussed alternatives and uncertainties with a qualified healthcare professional.

The decision should be individualized rather than driven by the assumption that “more technology” automatically means better results.

Questions to Ask Before Choosing Exosome Microneedling

Before treatment, ask:

1. What exact product are you using?

Ask for the complete product name.

2. What is the source of the product?

Ask whether the preparation is human-derived, plant-derived or produced by another method.

3. Has this exact product been studied in humans?

Research involving another exosome preparation does not necessarily validate the product being offered to you.

4. Is the product FDA approved?

FDA currently states that there are no FDA-approved exosome products.

5. What microneedling device is being used?

Ask for the manufacturer and model.

6. What is the FDA-authorized indication for that device?

Authorization is device-specific.

7. Is the exosome-containing product being introduced into the skin?

This matters because FDA has not cleared microneedling devices for use with another product.

8. What evidence supports the exact treatment protocol?

Ask whether the research matches:

• The product
• The route
• The concentration
• The treatment depth
• The number of sessions

9. What are the alternatives?

Depending on the problem, alternatives may include conventional microneedling, laser procedures, chemical peels, injectables, topical therapies or other approaches.

Who Is a Good Candidate for Conventional Microneedling?

Microneedling may be considered for adults seeking improvement in selected concerns such as:

• Facial wrinkles
• Fine lines
• Uneven skin texture
• Certain atrophic acne scars
• Some signs of photodamage

However, candidacy should be determined individually.

Who May Not Be a Good Candidate?

Microneedling may not be appropriate for some people with:

• Active skin infection
• Active inflammatory skin disease
• Active cold sores
• Certain bleeding disorders
• Certain immune-system disorders
• Uncontrolled diabetes
• A tendency toward abnormal scarring
• Recent isotretinoin use in certain circumstances
• Significant sun exposure or a recent tan
• Certain medications or medical conditions

FDA recommends discussing candidacy, risks and expected benefits with a trained healthcare provider.

How Many Treatments Are Needed?

There is no single number that applies to everyone.

Treatment plans depend on:

• The condition being treated
• Severity
• Treatment depth
• Skin type
• Healing response
• Treatment goals
• Whether additional procedures are being used

Importantly, there is no universally established evidence-based treatment schedule for microneedling with exosomes.

Published studies use different protocols.

That is another reason treatment plans should not be copied directly from an unrelated study or advertisement.

What Does Recovery Look Like?

Conventional microneedling can produce temporary:

• Redness
• Sensitivity
• Tightness
• Dryness
• Peeling
• Mild swelling
• Bruising
• Pinpoint bleeding

The intensity and duration depend on the treatment settings and individual response. After treatment, skin may also be more sensitive to sunlight and certain skincare ingredients.

Follow the specific aftercare instructions provided by your healthcare provider.

The Bottom Line: Microneedling or Microneedling With Exosomes?

If you want the simplest evidence-based answer:

Conventional microneedling currently has the stronger and more established clinical evidence base. Microneedling with exosomes is an interesting emerging treatment that may provide additional benefits, and early human studies are encouraging.

But there is not yet enough evidence to say that adding exosomes is universally better than microneedling alone.

The most important facts are:

• Microneedling itself has a substantial clinical literature.
• Certain microneedling devices have FDA marketing authorization for specific indications.
• Exosome-assisted microneedling is a newer field.
• Human studies are promising but generally small.
• Exosome preparations are heterogeneous.
• FDA states that there are currently no FDA-approved exosome products.
• FDA has not cleared microneedling devices for use with another product.
• The superiority of exosome microneedling over conventional microneedling has not been established.
• The right treatment depends on the patient’s skin concern, medical history, skin characteristics and treatment goals.

In other words, exosomes may eventually prove to add meaningful benefits to microneedling—but the science has not reached the point where that conclusion can be considered established.

Why Medical Guidance Matters

Emerging aesthetic treatments can be difficult to evaluate because marketing often moves faster than clinical evidence. A responsible consultation should distinguish among:

What is biologically plausible

What has been demonstrated in human studies

What has been demonstrated in larger controlled trials

What has received FDA authorization

What remains uncertain

That distinction is particularly important with exosome-based treatments because the products themselves are not standardized in the same way as an FDA-approved medication or a specific FDA-authorized medical device.

About Dr. Monica Gavin, MD, MBA

Dr. Monica Gavin, MD, MBA, is the owner and Medical Director of Azani Medical Spa in Bethlehem, Pennsylvania. She has more than 28 years of medical experience and oversees clinical protocols and patient-centered aesthetic services at the practice.

Her approach to aesthetic medicine emphasizes patient education and individualized treatment decisions rather than assuming that the newest treatment is automatically the best treatment.

For patients considering microneedling or emerging exosome-based treatments, that means evaluating the specific skin concern, expected benefit, risks, alternatives and strength of the available evidence.

Ready to Find Out Which Treatment Is Right for Your Skin?

The best treatment is not necessarily the newest one. It is the treatment that makes sense for your skin, your goals and your risk-benefit profile.

At Azani Medical Spa in Bethlehem, PA, a consultation can help determine whether conventional microneedling, an exosome-based approach or another treatment is appropriate for your individual goals.

Call 610-625-3000 to schedule your consultation.

Medical Disclaimer

This article is intended for general educational purposes and should not be considered individualized medical advice, diagnosis or treatment. Microneedling and exosome-containing treatments may not be appropriate for every patient. Risks, benefits, alternatives and candidacy should be discussed with a qualified healthcare professional who can evaluate your individual circumstances.

FDA regulatory status and clinical evidence can change as new research becomes available. Patients should verify the current regulatory status of any product or device before treatment.

Last reviewed/updated: September 2026